ArticleClinical immunology communications2023

Is Interleukin-6 blockade a viable strategy to prevent progression of acute respiratory distress syndrome in non-COVID viral pneumonia?

Rana Prathap Padappayil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.